Selective depression of T‐lymphocyte subsets in gastric cancer patients: An implication of immunotherapy
- 1 March 1994
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 55 (3) , 165-169
- https://doi.org/10.1002/jso.2930550307
Abstract
The lymphocytes and their subsets were determined in the peripheral blood of 62 gastric cancer patients and 68 controls using fluorescent conjugated monoclonal antibodies and flow cytometry (FACScan method). A significant increase in the total number of white blood cells from gastric cancer patients was noted in comparison to controls, but the percentage of lymphocytes was the same. The percentage of suppressor (cytotoxic) T cells (CD8) showed no difference in all stages of gastric cancer patients evaluated, but the percentage of helper (inducer) T cells (CD4) and the CD4/ CD8 ratio decreased significantly in the advanced stages III and IV. Depression of the CD4/CD8 ratio was well correlated with tumor invasion, lymph node metastasis, and tumor size but not with sex, age, tumor location, gross type, or histologic differentiation. It appeared that the immune defect of gastric cancer patients was associated with the afferent arm (CD4) and worsened as the disease advanced. These results suggest that immunotherapy to stimulate the deficient immune system may play an important part in the multimodality treatment of patients with advanced gastric cancer. © Wiley-Liss, Inc.Keywords
This publication has 18 references indexed in Scilit:
- Tumor Eradication by Adoptive Transfer of Cytototic T LymphocytesPublished by Elsevier ,1992
- Adenocarcinoma of the stomach: A review of 35 years and 1,710 casesWorld Journal of Surgery, 1990
- Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applicationsHuman Immunology, 1990
- Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cellsCancer Immunology, Immunotherapy, 1990
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancerBritish Journal of Surgery, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCERThe Lancet, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Characterization of cell-mediated immunity in long-term survivors of gastric or colorectal cancerThe American Journal of Surgery, 1984